Saudi Pharmaceutical Industries and Medical Appliances Corporation
Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
2070.sr · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) measures how much investors pay for each dollar of the company's trailing earnings. 2070.SR's current PE ratio of 19.97x is calculated by dividing its stock price of $28.50 by its TTM earnings per share of $1.43. −76.4% discount vs 5Y avg 84.7x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 17 fiscal years · Front-end computedMinQ1 · 25%15.8x
MedianQ3 · 75%178.5x
Max
At 19.97x, 2070.SR's current P/E is higher than in 76% of its annual fiscal year readings over the past 17 years — historically elevated.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Saudi Pharmaceutical Industries and Medical Appliances CorporationYou 2070.SR | $3.4B | 19.97x | +0.3% | $1.43 |
 Al Hammadi Holding Company 4007.SR | $4.5B | 18.53x | -7.0% | $1.51 |
 Middle East Healthcare Company 4009.SR | $3.0B | 9.93x | -50.2% | $3.28 |
 Scientific and Medical Equipment House Company 4014.SR | $945M | 33.39x | +67.6% | $0.95 |
 Jamjoom Pharmaceuticals Factory Company 4015.SR | $11.2B | 21.56x | +8.3% | $6.60 |
 Middle East Pharmaceutical Industries Company 4016.SR | $2.2B | 22.93x | +15.1% | $2.77 |
 Al-Dawaa Medical Services Company 4163.SR | $3.7B | 13.17x | -33.9% | $3.79 |
Industry Average 6 peers with valid PE | — | 19.92x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | 16.92x | $1.54 | -89.2% | |
2024-12-31 FY2024 | 156.27x | $0.20 | — | |
2023-12-31 FY2023 | — | $-0.11 | — | |
2022-12-31 FY2022 | — | $-1.42 | — | |
2021-12-31 FY2021 | 178.50x | $0.22 | +373.5% | |
2020-12-31 FY2020 | 37.70x | $1.04 | — | |
2019-12-31 FY2019 | — | $-4.01 | — | |
2018-12-31 FY2018 | 34.31x | $0.86 | +85.0% | |
2017-12-31 FY2017 | 18.54x | $1.64 | +47.4% | |
2016-12-31 FY2016 | 12.58x | $3.14 | +12.8% |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR) measures how much investors pay for each dollar of the company's trailing earnings. 2070.SR's current PE ratio of 19.97x is calculated by dividing its stock price of $28.50 by its TTM earnings per share of $1.43.
Frequently asked questions
2070.SR pe ratio · 6 questions2070.SR's current PE ratio is 19.97x as of 2026-06-15, based on a stock price of $28.50 and TTM EPS of $1.43. Data sourced from Financial Modeling Prep via 2070.SR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Saudi Pharmaceutical Industries and Medical Appliances Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-15